AICD nuclear signaling and its possible contribution to Alzheimer's disease

Current Alzheimer Research

Volumn 9, Issue 2, 2012, Pages 200-216

  Konietzko, Uwe ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

AICD; Alzheimer's disease; Amyloid precursor protein; APP; Endosome; Fe65; Nuclear signaling; Regulated intramembrane proteolysis; RIP; Synapse

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; BETA AMYLOID PRECURSOR PROTEIN INTRACELLULAR DOMAIN; GAMMA SECRETASE; NOTCH RECEPTOR; PRESENILIN 1; PROTEIN FE65; TRANSCRIPTION FACTOR GAL4; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ARTICLE; ENDOCYTOSIS; GENE CONTROL; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REGULATED INTRAMEMBRANE PROTEOLYSIS; SIGNAL TRANSDUCTION; SYNAPSE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; HUMANS; INTRACELLULAR FLUID; PROTEIN STRUCTURE, TERTIARY; SIGNAL TRANSDUCTION;

EID: 84857720147     PISSN: 15672050     EISSN: 18755828     Source Type: Journal    
DOI: 10.2174/156720512799361673     Document Type: Article

References (252)

1. Alzheimer A. Über eine eigenartige Erkrankung der Hirnrinde. Zentralblatt für Nervenheilkunde und Psychiatrie 30: 177-9 (1907).
2. Glenner GG, Wong CW. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120(3): 885-90 (1984).
3. Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH, et al. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature 325(6106): 733-6 (1987).
4. Tanzi RE, Gusella JF, Watkins PC, Bruns GA, St George-Hyslop P, Van Keuren ML, et al. Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science 235(4791): 880-4 (1987).
5. Gotz J, Chen F, van Dorpe J, Nitsch RM. Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils. Science 293(5534): 1491-5 (2001).
6. Lewis J, Dickson DW, Lin WL, Chisholm L, Corral A, Jones G, et al. Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 293(5534): 1487-91 (2001).
7. De Strooper B, Annaert W. Proteolytic processing and cell biological functions of the amyloid precursor protein. J Cell Sci 113 (Pt 11): 1857-70 (2000).
8. Fraering PC, Ye W, Strub JM, Dolios G, LaVoie MJ, Ostaszewski BL, et al. Purification and characterization of the human gammasecretase complex. Biochemistry 43(30): 9774-89 (2004).
9. Hardy JA, Higgins GA. Alzheimer's disease: the amyloid cascade hypothesis. Science 256(5054): 184-5 (1992).
10. Arriagada PV, Growdon JH, Hedley-Whyte ET, Hyman BT. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 42(3 Pt 1): 631-9 (1992).
11. Erten-Lyons D, Woltjer RL, Dodge H, Nixon R, Vorobik R, Calvert JF, et al. Factors associated with resistance to dementia despite high Alzheimer disease pathology. Neurology 72(4): 354-60 (2009).
12. Snowdon DA. Healthy aging and dementia: findings from the Nun Study. Ann Intern Med 139(5 Pt 2): 450-4 (2003).
13. Terry RD, Masliah E, Salmon DP, Butters N, DeTeresa R, Hill R, et al. Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann Neurol 30(4): 572-80 (1991).
14. Cleary JP, Walsh DM, Hofmeister JJ, Shankar GM, Kuskowski MA, Selkoe DJ, et al. Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat Neurosci 8(1): 79-84 (2005).
15. Cuajungco MP, Goldstein LE, Nunomura A, Smith MA, Lim JT, Atwood CS, et al. Evidence that the beta-amyloid plaques of Alzheimer's disease represent the redox-silencing and entombment of abeta by zinc. J Biol Chem 275(26): 19439-42 (2000).
16. Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, et al. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416(6880): 535-9 (2002).
17. Hsieh H, Boehm J, Sato C, Iwatsubo T, Tomita T, Sisodia S, et al. AMPAR Removal Underlies Abeta-Induced Synaptic Depression and Dendritic Spine Loss. Neuron 52(5): 831-43 (2006).
18. Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297(5580): 353-6 (2002).
19. Dodart JC, Bales KR, Gannon KS, Greene SJ, DeMattos RB, Mathis C, et al. Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer's disease model. Nat Neurosci 5(5): 452-7 (2002).
20. Saura CA, Choi SY, Beglopoulos V, Malkani S, Zhang D, Shankaranarayana Rao BS, et al. Loss of presenilin function causes impairments of memory and synaptic plasticity followed by agedependent neurodegeneration. Neuron 42(1): 23-36 (2004).
21. Shen J, Kelleher RJ, 3rd. The presenilin hypothesis of Alzheimer's disease: evidence for a loss-of-function pathogenic mechanism. Proc Natl Acad Sci USA 104(2): 403-9 (2007).
22. Mattson MP, Cheng B, Culwell AR, Esch FS, Lieberburg I, Rydel RE. Evidence for excitoprotective and intraneuronal calciumregulating roles for secreted forms of the beta-amyloid precursor protein. Neuron 10(2): 243-54 (1993).
23. Ohsawa I, Takamura C, Morimoto T, Ishiguro M, Kohsaka S. Amino-terminal region of secreted form of amyloid precursor protein stimulates proliferation of neural stem cells. Eur J Neurosci 11(6): 1907-13 (1999).
24. Jin LW, Ninomiya H, Roch JM, Schubert D, Masliah E, Otero DA, et al. Peptides containing the RERMS sequence of amyloid beta/A4 protein precursor bind cell surface and promote neurite extension. J Neurosci 14(9): 5461-70 (1994).
25. Ring S, Weyer SW, Kilian SB, Waldron E, Pietrzik CU, Filippov MA, et al. The secreted beta-amyloid precursor protein ectodomain APPs alpha is sufficient to rescue the anatomical, behavioral, and electrophysiological abnormalities of APP-deficient mice. J Neurosci 27(29): 7817-26 (2007).
26. Zheng H, Jiang M, Trumbauer ME, Sirinathsinghji DJ, Hopkins R, Smith DW, et al. beta-Amyloid precursor protein-deficient mice show reactive gliosis and decreased locomotor activity. Cell 81(4): 525-31 (1995).
27. Heber S, Herms J, Gajic V, Hainfellner J, Aguzzi A, Rulicke T, et al. Mice with combined gene knock-outs reveal essential and partially redundant functions of amyloid precursor protein family members. J Neurosci 20(21): 7951-63 (2000).
28. Li H, Wang B, Wang Z, Guo Q, Tabuchi K, Hammer RE, et al. Soluble amyloid precursor protein (APP) regulates transthyretin and Klotho gene expression without rescuing the essential function of APP. Proc Natl Acad Sci USA 107(40): 17362-7 (2010).
29. Li H, Wang Z, Wang B, Guo Q, Dolios G, Tabuchi K, et al. Genetic dissection of the amyloid precursor protein in developmental function and amyloid pathogenesis. J Biol Chem 285(40): 30598-605 (2010).
30. Nikolaev A, McLaughlin T, O'Leary DD, Tessier-Lavigne M. APP binds DR6 to trigger axon pruning and neuron death via distinct caspases. Nature 457(7232): 981-9 (2009).
31. De Strooper B, Annaert W, Cupers P, Saftig P, Craessaerts K, Mumm JS, et al. A presenilin-1-dependent gamma-secretase-like protease mediates release of Notch intracellular domain. Nature 398(6727): 518-22 (1999).
32. Schroeter EH, Kisslinger JA, Kopan R. Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain. Nature 393(6683): 382-6 (1998).
33. Passer B, Pellegrini L, Russo C, Siegel RM, Lenardo MJ, Schettini G, et al. Generation of an Apoptotic Intracellular Peptide by gamma-Secretase Cleavage of Alzheimer's Amyloid beta Protein Precursor. J Alzheimers Dis 2(3,4): 289-301 (2000).
34. Weidemann A, Eggert S, Reinhard FB, Vogel M, Paliga K, Baier G, et al. A novel epsilon-cleavage within the transmembrane domain of the Alzheimer amyloid precursor protein demonstrates homology with Notch processing. Biochemistry 41(8): 2825-35 (2002).
35. Gu Y, Misonou H, Sato T, Dohmae N, Takio K, Ihara Y. Distinct intramembrane cleavage of the beta-amyloid precursor protein family resembling gamma-secretase-like cleavage of Notch. J Biol Chem 276(38): 35235-8 (2001).
36. Sastre M, Steiner H, Fuchs K, Capell A, Multhaup G, Condron MM, et al. Presenilin-dependent gamma-secretase processing of beta-amyloid precursor protein at a site corresponding to the S3 cleavage of Notch. EMBO Rep 2(9): 835-41 (2001).
37. Kakuda N, Funamoto S, Yagishita S, Takami M, Osawa S, Dohmae N, et al. Equimolar production of amyloid beta-protein and amyloid precursor protein intracellular domain from betacarboxyl-terminal fragment by gamma-secretase. J Biol Chem 281(21): 14776-86 (2006).
38. Takami M, Nagashima Y, Sano Y, Ishihara S, Morishima-Kawashima M, Funamoto S, et al. gamma-Secretase: successive tripeptide and tetrapeptide release from the transmembrane domain of beta-carboxyl terminal fragment. J Neurosci 29(41): 13042-52 (2009).
39. Funamoto S, Morishima-Kawashima M, Tanimura Y, Hirotani N, Saido TC, Ihara Y. Truncated carboxyl-terminal fragments of betaamyloid precursor protein are processed to amyloid beta-proteins 40 and 42. Biochemistry 43(42): 13532-40 (2004).
40. Cupers P, Orlans I, Craessaerts K, Annaert W, De Strooper B. The amyloid precursor protein (APP)-cytoplasmic fragment generated by gamma-secretase is rapidly degraded but distributes partially in a nuclear fraction of neurones in culture. J Neurochem 78(5): 1168-78 (2001).
41. Edbauer D, Willem M, Lammich S, Steiner H, Haass C. Insulindegrading enzyme rapidly removes the beta-amyloid precursor protein intracellular domain (AICD). J Biol Chem 277(16): 13389-93 (2002).
42. Farris W, Mansourian S, Chang Y, Lindsley L, Eckman EA, Frosch MP, et al. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci USA 100(7): 4162-7 (2003).
43. Vingtdeux V, Hamdane M, Begard S, Loyens A, Delacourte A, Beauvillain JC, et al. Intracellular pH regulates amyloid precursor protein intracellular domain accumulation. Neurobiol Dis 25(3): 686-96 (2007).
44. Duilio A, Zambrano N, Mogavero AR, Ammendola R, Cimino F, Russo T. A rat brain mRNA encoding a transcriptional activator homologous to the DNA binding domain of retroviral integrases. Nucleic Acids Res 19(19): 5269-74 (1991).
45. Zambrano N, Buxbaum JD, Minopoli G, Fiore F, De Candia P, De Renzis S, et al. Interaction of the phosphotyrosine interaction/phosphotyrosine binding-related domains of Fe65 with wild-type and mutant Alzheimer's beta-amyloid precursor proteins. J Biol Chem 272(10): 6399-405 (1997).
46. Borg JP, Ooi J, Levy E, Margolis B. The phosphotyrosine interaction domains of X11 and FE65 bind to distinct sites on the YENPTY motif of amyloid precursor protein. Mol Cell Biol 16(11): 6229-41 (1996).
47. Minopoli G, de Candia P, Bonetti A, Faraonio R, Zambrano N, Russo T. The beta-amyloid precursor protein functions as a cytosolic anchoring site that prevents Fe65 nuclear translocation. J Biol Chem 276(9): 6545-50 (2001).
48. Kimberly WT, Zheng JB, Guenette SY, Selkoe DJ. The intracellular domain of the beta-amyloid precursor protein is stabilized by Fe65 and translocates to the nucleus in a notch-like manner. J Biol Chem 276(43): 40288-92 (2001).
49. Kinoshita A, Whelan CM, Smith CJ, Berezovska O, Hyman BT. Direct visualization of the gamma secretase-generated carboxylterminal domain of the amyloid precursor protein: association with Fe65 and translocation to the nucleus. J Neurochem 82(4): 839-47 (2002).
50. Cao X, Sudhof TC. A transcriptionally [correction of transcriptively] active complex of APP with Fe65 and histone acetyltransferase Tip60. Science 293(5527): 115-20 (2001).
51. Sterner DE, Berger SL. Acetylation of histones and transcriptionrelated factors. Microbiol Mol Biol Rev 64(2): 435-59 (2000).
52. Zambrano N, Minopoli G, de Candia P, Russo T. The Fe65 adaptor protein interacts through its PID1 domain with the transcription factor CP2/LSF/LBP1. J Biol Chem 273(32): 20128-33 (1998).
53. Kim HS, Kim EM, Lee JP, Park CH, Kim S, Seo JH, et al. Cterminal fragments of amyloid precursor protein exert neurotoxicity by inducing glycogen synthase kinase-3beta expression. FASEB J 17(13): 1951-3 (2003).
54. von Rotz RC, Kohli BM, Bosset J, Meier M, Suzuki T, Nitsch RM, et al. The APP intracellular domain forms nuclear multiprotein complexes and regulates the transcription of its own precursor. J Cell Sci 117(Pt 19): 4435-48 (2004).
55. Konietzko U, Goodger ZV, Meyer M, Kohli BM, Bosset J, Lahiri DK, et al. Co-localization of the amyloid precursor protein and Notch intracellular domains in nuclear transcription factories. Neurobiol Aging 31(1): 58-73 (2008).
56. Borg JP, Yang Y, De Taddeo-Borg M, Margolis B, Turner RS. The X11alpha protein slows cellular amyloid precursor protein processing and reduces Abeta40 and Abeta42 secretion. J Biol Chem 273(24): 14761-6 (1998).
57. Biederer T, Cao X, Sudhof TC, Liu X. Regulation of APPdependent transcription complexes by Mint/X11s: differential functions of Mint isoforms. J Neurosci 22(17): 7340-51 (2002).
58. Matsuda S, Yasukawa T, Homma Y, Ito Y, Niikura T, Hiraki T, et al. c-Jun N-terminal kinase (JNK)-interacting protein-1b/isletbrain- 1 scaffolds Alzheimer's amyloid precursor protein with JNK. J Neurosci 21(17): 6597-607 (2001).
59. Taru H, Kirino Y, Suzuki T. Differential roles of JIP scaffold proteins in the modulation of amyloid precursor protein metabolism. J Biol Chem 277(30): 27567-74 (2002).
60. Scheinfeld MH, Matsuda S, D'Adamio L. JNK-interacting protein- 1 promotes transcription of A beta protein precursor but not A beta precursor-like proteins, mechanistically different than Fe65. Proc Natl Acad Sci USA 100(4): 1729-34 (2003).
61. Tamayev R, Zhou D, D'Adamio L. The interactome of the amyloid beta precursor protein family members is shaped by phosphorylation of their intracellular domains. Mol Neurodegener 4: 28 (2009).
62. Sumioka A, Nagaishi S, Yoshida T, Lin A, Miura M, Suzuki T. Role of 14-3-3gamma in FE65-dependent gene transactivation mediated by the amyloid beta-protein precursor cytoplasmic fragment. J Biol Chem 280(51): 42364-74 (2005).
63. Telese F, Bruni P, Donizetti A, Gianni D, D'Ambrosio C, Scaloni A, et al. Transcription regulation by the adaptor protein Fe65 and the nucleosome assembly factor SET. EMBO Rep 6(1): 77-82 (2005).
64. Lau KF, Chan WM, Perkinton MS, Tudor EL, Chang RC, Chan HY, et al. Dexras1 interacts with FE65 to regulate FE65-amyloid precursor protein-dependent transcription. J Biol Chem 283(50): 34728-37 (2008).
65. Lee MR, Lee D, Shin SK, Kim YH, Choi CY. Inhibition of APP intracellular domain (AICD) transcriptional activity via covalent conjugation with Nedd8. Biochem Biophys Res Commun 366(4): 976-81 (2008).
66. Kajiwara Y, Akram A, Katsel P, Haroutunian V, Schmeidler J, Beecham G, et al. FE65 binds Teashirt, inhibiting expression of the primate-specific caspase-4. PLoS ONE 4(4): e5071 (2009).
67. Lau KF, McLoughlin DM, Standen CL, Irving NG, Miller CC. Fe65 and X11beta co-localize with and compete for binding to the amyloid precursor protein. Neuroreport 11(16): 3607-10 (2000).
68. Radzimanowski J, Simon B, Sattler M, Beyreuther K, Sinning I, Wild K. Structure of the intracellular domain of the amyloid precursor protein in complex with Fe65-PTB2. EMBO Rep: (2008).
69. Bressler SL, Gray MD, Sopher BL, Hu Q, Hearn MG, Pham DG, et al. cDNA cloning and chromosome mapping of the human Fe65 gene: interaction of the conserved cytoplasmic domains of the human beta-amyloid precursor protein and its homologues with the mouse Fe65 protein. Hum Mol Genet 5(10): 1589-98 (1996).
70. Yang Z, Cool BH, Martin GM, Hu Q. A dominant role for FE65 (APBB1) in nuclear signaling. J Biol Chem 281(7): 4207-14 (2006).
71. Cao X, Sudhof TC. Dissection of amyloid-beta precursor proteindependent transcriptional transactivation. J Biol Chem 279(23): 24601-11 (2004).
72. Herms J, Anliker B, Heber S, Ring S, Fuhrmann M, Kretzschmar H, et al. Cortical dysplasia resembling human type 2 lissencephaly in mice lacking all three APP family members. Embo J 23(20): 4106-15 (2004).
73. Guenette S, Chang Y, Hiesberger T, Richardson JA, Eckman CB, Eckman EA, et al. Essential roles for the FE65 amyloid precursor protein-interacting proteins in brain development. Embo J 25(2): 420-31 (2006).
74. McLoughlin DM, Miller CC. The FE65 proteins and Alzheimer's disease. J Neurosci Res 86(4): 744-54 (2008).
75. Zambrano N, Bimonte M, Arbucci S, Gianni D, Russo T, Bazzicalupo P. feh-1 and apl-1, the Caenorhabditis elegans orthologues of mammalian Fe65 and beta-amyloid precursor protein genes, are involved in the same pathway that controls nematode pharyngeal pumping. J Cell Sci 115(Pt 7): 1411-22 (2002).
76. Sabo SL, Ikin AF, Buxbaum JD, Greengard P. The amyloid precursor protein and its regulatory protein, FE65, in growth cones and synapses in vitro and in vivo. J Neurosci 23(13): 5407-15 (2003).
77. McCarthy JV, Twomey C, Wujek P. Presenilin-dependent regulated intramembrane proteolysis and gamma-secretase activity. Cell Mol Life Sci 66(9): 1534-55 (2009).
78. Hemming ML, Elias JE, Gygi SP, Selkoe DJ. Proteomic profiling of gamma-secretase substrates and mapping of substrate requirements. PLoS Biol 6(10): e257 (2008).
79. Selkoe DJ, Wolfe MS. Presenilin: running with scissors in the membrane. Cell 131(2): 215-21 (2007).
80. Lazarov VK, Fraering PC, Ye W, Wolfe MS, Selkoe DJ, Li H. Electron microscopic structure of purified, active gamma-secretase reveals an aqueous intramembrane chamber and two pores. Proc Natl Acad Sci USA 103(18): 6889-94 (2006).
81. Fortini ME. Gamma-secretase-mediated proteolysis in cell-surfacereceptor signalling. Nat Rev Mol Cell Biol 3(9): 673-84 (2002).
82. Frykman S, Hur JY, Franberg J, Aoki M, Winblad B, Nahalkova J, et al. Synaptic and endosomal localization of active gammasecretase in rat brain. PLoS One 5(1): e8948 (2010).
83. Ribaut-Barassin C, Moussaoui S, Brugg B, Haeberle AM, Huber G, Imperato A, et al. Hemisynaptic distribution patterns of presenilins and beta-APP isoforms in the rodent cerebellum and hippocampus. Synapse 35(2): 96-110 (2000).
84. Zhang C, Wu B, Beglopoulos V, Wines-Samuelson M, Zhang D, Dragatsis I, et al. Presenilins are essential for regulating neurotransmitter release. Nature 460(7255): 632-6 (2009).
85. Tang L, Hung CP, Schuman EM. A role for the cadherin family of cell adhesion molecules in hippocampal long-term potentiation. Neuron 20(6): 1165-75 (1998).
86. Bot N, Schweizer C, Ben Halima S, Fraering PC. Processing of the Synaptic Cell Adhesion Molecule Neurexin-3{beta} by Alzheimer Disease {alpha}- and {gamma}-Secretases. J Biol Chem 286(4): 2762-73 (2011).
87. Li B, Woo RS, Mei L, Malinow R. The neuregulin-1 receptor erbB4 controls glutamatergic synapse maturation and plasticity. Neuron 54(4): 583-97 (2007).
88. Hodgkinson GN, Tresco PA, Hlady V. The influence of sub-micron inhibitory clusters on growth cone substratum attachments and CD44 expression. Biomaterials 29(31): 4227-35 (2008).
89. Vogt L, Schrimpf SP, Meskenaite V, Frischknecht R, Kinter J, Leone DP, et al. Calsyntenin-1, a proteolytically processed postsynaptic membrane protein with a cytoplasmic calcium-binding domain. Mol Cell Neurosci 17(1): 151-66 (2001).
90. Araki Y, Tomita S, Yamaguchi H, Miyagi N, Sumioka A, Kirino Y, et al. Novel cadherin-related membrane proteins, Alcadeins, enhance the X11-like protein-mediated stabilization of amyloid beta -protein precursor metabolism. J Biol Chem (2003).
91. Inoue E, Deguchi-Tawarada M, Togawa A, Matsui C, Arita K, Katahira-Tayama S, et al. Synaptic activity prompts gammasecretase-mediated cleavage of EphA4 and dendritic spine formation. J Cell Biol 185(3): 551-64 (2009).
92. Georgakopoulos A, Litterst C, Ghersi E, Baki L, Xu C, Serban G, et al. Metalloproteinase/Presenilin1 processing of ephrinB regulates EphB-induced Src phosphorylation and signaling. EMBO J 25(6): 1242-52 (2006).
93. Tomita T, Tanaka S, Morohashi Y, Iwatsubo T. Presenilindependent intramembrane cleavage of ephrin-B1. Mol Neurodegener 1: 2 (2006).
94. Litterst C, Georgakopoulos A, Shioi J, Ghersi E, Wisniewski T, Wang R, et al. Ligand binding and calcium influx induce distinct ectodomain/gamma-secretase-processing pathways of EphB2 receptor. J Biol Chem 282(22): 16155-63 (2007).
95. Herz J. Apolipoprotein E receptors in the nervous system. Curr Opin Lipidol 20(3): 190-6 (2009).
96. Hoe HS, Rebeck GW. Regulation of ApoE receptor proteolysis by ligand binding. Brain Res Mol Brain Res 137(1-2): 31-9 (2005).
97. Lammich S, Okochi M, Takeda M, Kaether C, Capell A, Zimmer AK, et al. Presenilin-dependent intramembrane proteolysis of CD44 leads to the liberation of its intracellular domain and the secretion of an Abeta-like peptide. J Biol Chem 277(47): 44754-9 (2002).
98. Ni CY, Murphy MP, Golde TE, Carpenter G. gamma -Secretase cleavage and nuclear localization of ErbB-4 receptor tyrosine kinase. Science 294(5549): 2179-81 (2001).
99. Bao J, Wolpowitz D, Role LW, Talmage DA. Back signaling by the Nrg-1 intracellular domain. J Cell Biol 161(6): 1133-41 (2003).
100. Marambaud P, Wen PH, Dutt A, Shioi J, Takashima A, Siman R, et al. A CBP binding transcriptional repressor produced by the PS1/epsilon-cleavage of N-cadherin is inhibited by PS1 FAD mutations. Cell 114(5): 635-45 (2003).
101. Okamoto I, Kawano Y, Murakami D, Sasayama T, Araki N, Miki T, et al. Proteolytic release of CD44 intracellular domain and its role in the CD44 signaling pathway. J Cell Biol 155(5): 755-62 (2001).
102. Bohm C, Seibel NM, Henkel B, Steiner H, Haass C, Hampe W. SorLA signaling by regulated intramembrane proteolysis. J Biol Chem 281(21): 14547-53 (2006).
103. Kinoshita A, Shah T, Tangredi MM, Strickland DK, Hyman BT. The intracellular domain of the low density lipoprotein receptorrelated protein modulates transactivation mediated by amyloid precursor protein and Fe65. J Biol Chem 278(42): 41182-8 (2003).
104. May P, Reddy YK, Herz J. Proteolytic processing of low density lipoprotein receptor-related protein mediates regulated release of its intracellular domain. J Biol Chem 277(21): 18736-43 (2002).
105. Savonenko AV, Melnikova T, Laird FM, Stewart KA, Price DL, Wong PC. Alteration of BACE1-dependent NRG1/ErbB4 signaling and schizophrenia-like phenotypes in BACE1-null mice. Proc Natl Acad Sci USA 105(14): 5585-90 (2008).
106. Tai CY, Mysore SP, Chiu C, Schuman EM. Activity-regulated Ncadherin endocytosis. Neuron 54(5): 771-85 (2007).
107. May P, Rohlmann A, Bock HH, Zurhove K, Marth JD, Schomburg ED, et al. Neuronal LRP1 functionally associates with postsynaptic proteins and is required for normal motor function in mice. Mol Cell Biol 24(20): 8872-83 (2004).
108. Ikeuchi T, Sisodia SS. The Notch ligands, Delta1 and Jagged2, are substrates for presenilin-dependent "gamma-secretase" cleavage. J Biol Chem 278(10): 7751-4 (2003).
109. Six E, Ndiaye D, Laabi Y, Brou C, Gupta-Rossi N, Israel A, et al. The Notch ligand Delta1 is sequentially cleaved by an ADAM protease and gamma-secretase. Proc Natl Acad Sci U S A 100(13): 7638-43 (2003).
110. LaVoie MJ, Selkoe DJ. The Notch ligands, Jagged and Delta, are sequentially processed by alpha-secretase and presenilin/gammasecretase and release signaling fragments. J Biol Chem 278(36): 34427-37 (2003).
111. Redmond L, Oh SR, Hicks C, Weinmaster G, Ghosh A. Nuclear Notch1 signaling and the regulation of dendritic development. Nat Neurosci 3(1): 30-40 (2000).
112. Sestan N, Artavanis-Tsakonas S, Rakic P. Contact-dependent inhibition of cortical neurite growth mediated by notch signaling. Science 286(5440): 741-6 (1999).
113. Wang Y, Chan SL, Miele L, Yao PJ, Mackes J, Ingram DK, et al. Involvement of Notch signaling in hippocampal synaptic plasticity. Proc Natl Acad Sci USA 101(25): 9458-62 (2004).
114. Schubert W, Prior R, Weidemann A, Dircksen H, Multhaup G, Masters CL, et al. Localization of Alzheimer beta A4 amyloid precursor protein at central and peripheral synaptic sites. Brain Res 563(1-2): 184-94 (1991).
115. Hoe HS, Fu Z, Makarova A, Lee JY, Lu C, Feng L, et al. The effects of amyloid precursor protein on postsynaptic composition and activity. J Biol Chem 284(13): 8495-506 (2009).
116. Cousins SL, Hoey SE, Stephenson FA, Perkinton MS. Amyloid Precursor Protein 695 Associates With Assembled Nr2a-And Nr2b-Containing Nmda Receptors To Result In The Enhancement Of Their Cell Surface Delivery. J Neurochem: (2009).
117. Soba P, Eggert S, Wagner K, Zentgraf H, Siehl K, Kreger S, et al. Homo- and heterodimerization of APP family members promotes intercellular adhesion. Embo J 24(20): 3624-34 (2005).
118. Scheinfeld MH, Ghersi E, Laky K, Fowlkes BJ, D'Adamio L. Processing of beta-amyloid precursor-like protein-1 and -2 by gamma-secretase regulates transcription. J Biol Chem 277(46): 44195-201 (2002).
119. Lubman OY, Korolev SV, Kopan R. Anchoring notch genetics and biochemistry; structural analysis of the ankyrin domain sheds light on existing data. Mol Cell 13(5): 619-26 (2004).
120. Klueg KM, Muskavitch MA. Ligand-receptor interactions and trans-endocytosis of Delta, Serrate and Notch: members of the Notch signalling pathway in Drosophila. J Cell Sci 112 (Pt 19): 3289-97 (1999).
121. Wang B, Yang L, Wang Z, Zheng H. Amyolid precursor protein mediates presynaptic localization and activity of the high-affinity choline transporter. Proc Natl Acad Sci USA 104(35): 14140-5 (2007).
122. Yang G, Gong YD, Gong K, Jiang WL, Kwon E, Wang P, et al. Reduced synaptic vesicle density and active zone size in mice lacking amyloid precursor protein (APP) and APP-like protein 2. Neurosci Lett 384(1-2): 66-71 (2005).
123. Wang P, Yang G, Mosier DR, Chang P, Zaidi T, Gong YD, et al. Defective neuromuscular synapses in mice lacking amyloid precursor protein (APP) and APP-Like protein 2. J Neurosci 25(5): 1219-25 (2005).
124. Wang Z, Wang B, Yang L, Guo Q, Aithmitti N, Songyang Z, et al. Presynaptic and postsynaptic interaction of the amyloid precursor protein promotes peripheral and central synaptogenesis. J Neurosci 29(35): 10788-801 (2009).
125. Jordan BA, Kreutz MR. Nucleocytoplasmic protein shuttling: the direct route in synapse-to-nucleus signaling. Trends Neurosci 32(7): 392-401 (2009).
126. Greer PL, Greenberg ME. From synapse to nucleus: calciumdependent gene transcription in the control of synapse development and function. Neuron 59(6): 846-60 (2008).
127. Kamenetz F, Tomita T, Hsieh H, Seabrook G, Borchelt D, Iwatsubo T, et al. APP processing and synaptic function. Neuron 37(6): 925-37 (2003).
128. Cirrito JR, Yamada KA, Finn MB, Sloviter RS, Bales KR, May PC, et al. Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. Neuron 48(6): 913-22 (2005).
129. Goodger ZV, Rajendran L, Trutzel A, Kohli BM, Nitsch RM, Konietzko U. Nuclear signaling by the APP intracellular domain occurs predominantly through the amyloidogenic processing pathway. J Cell Sci 122(Pt 20): 3703-14 (2009).
130. Seabrook GR, Smith DW, Bowery BJ, Easter A, Reynolds T, Fitzjohn SM, et al. Mechanisms contributing to the deficits in hippocampal synaptic plasticity in mice lacking amyloid precursor protein. Neuropharmacology 38(3): 349-59 (1999).
131. Fitzjohn SM, Morton RA, Kuenzi F, Davies CH, Seabrook GR, Collingridge GL. Similar levels of long-term potentiation in amyloid precursor protein -null and wild-type mice in the CA1 region of picrotoxin treated slices. Neurosci Lett 288(1): 9-12 (2000).
132. Phinney AL, Calhoun ME, Wolfer DP, Lipp HP, Zheng H, Jucker M. No hippocampal neuron or synaptic bouton loss in learningimpaired aged beta-amyloid precursor protein-null mice. Neuroscience 90(4): 1207-16 (1999).
133. Dawson GR, Seabrook GR, Zheng H, Smith DW, Graham S, O'Dowd G, et al. Age-related cognitive deficits, impaired longterm potentiation and reduction in synaptic marker density in mice lacking the beta-amyloid precursor protein. Neuroscience 90(1): 1-13 (1999).
134. Senechal Y, Kelly PH, Dev KK. Amyloid precursor protein knockout mice show age-dependent deficits in passive avoidance learning. Behav Brain Res 186(1): 126-32 (2008).
135. Bittner T, Fuhrmann M, Burgold S, Jung CK, Volbracht C, Steiner H, et al. gamma-Secretase inhibition reduces spine density in vivo via an amyloid precursor protein-dependent pathway. J Neurosci 29(33): 10405-9 (2009).
136. Wang B, Hu Q, Hearn MG, Shimizu K, Ware CB, Liggitt DH, et al. Isoform-specific knockout of FE65 leads to impaired learning and memory. J Neurosci Res 75(1): 12-24 (2004).
137. Wang Y, Zhang M, Moon C, Hu Q, Wang B, Martin G, et al. The APP-interacting protein FE65 is required for hippocampusdependent learning and long-term potentiation. Learn Mem 16(9): 537-44 (2009).
138. Lamond AI, Earnshaw WC. Structure and function in the nucleus. Science 280(5363): 547-53 (1998).
139. Meaburn KJ, Misteli T. Cell biology: chromosome territories. Nature 445(7126): 379-781 (2007).
140. Mahy NL, Perry PE, Gilchrist S, Baldock RA, Bickmore WA. Spatial organization of active and inactive genes and noncoding DNA within chromosome territories. J Cell Biol 157(4): 579-89 (2002).
141. Cook PR. The organization of replication and transcription. Science 284(5421): 1790-5 (1999).
142. Misteli T. Beyond the sequence: cellular organization of genome function. Cell 128(4): 787-800 (2007).
143. Osborne CS, Chakalova L, Brown KE, Carter D, Horton A, Debrand E, et al. Active genes dynamically colocalize to shared sites of ongoing transcription. Nat Genet 36(10): 1065-71 (2004).
144. Carmo-Fonseca M, Platani M, Swedlow JR. Macromolecular mobility inside the cell nucleus. Trends Cell Biol 12(11): 491-5 (2002).
145. Phair RD, Misteli T. High mobility of proteins in the mammalian cell nucleus. Nature 404(6778): 604-9 (2000).
146. Platani M, Goldberg I, Swedlow JR, Lamond AI. In vivo analysis of Cajal body movement, separation, and joining in live human cells. J Cell Biol 151(7): 1561-74 (2000).
147. Muratani M, Gerlich D, Janicki SM, Gebhard M, Eils R, Spector DL. Metabolic-energy-dependent movement of PML bodies within the mammalian cell nucleus. Nat Cell Biol 4(2): 106-10 (2002).
148. Zeng C, Kim E, Warren SL, Berget SM. Dynamic relocation of transcription and splicing factors dependent upon transcriptional activity. Embo J 16(6): 1401-12 (1997).
149. Ma QH, Futagawa T, Yang WL, Jiang XD, Zeng L, Takeda Y, et al. A TAG1-APP signalling pathway through Fe65 negatively modulates neurogenesis. Nat Cell Biol 10(3): 283-94 (2008).
150. Schrenk-Siemens K, Perez-Alcala S, Richter J, Lacroix E, Rahuel J, Korte M, et al. Embryonic Stem Cell-derived Neurons as a Cellular System to Study Gene Function: Lack of Amyloid Precursor Proteins APP and APLP2 Leads to Defective Synaptic Transmission. Stem Cells: (2008).
151. Pardossi-Piquard R, Petit A, Kawarai T, Sunyach C, Alves da Costa C, Vincent B, et al. Presenilin-dependent transcriptional control of the Abeta-degrading enzyme neprilysin by intracellular domains of betaAPP and APLP. Neuron 46(4): 541-54 (2005).
152. Muller T, Concannon CG, Ward MW, Walsh CM, Tirniceriu AL, Tribl F, et al. Modulation of gene expression and cytoskeletal dynamics by the amyloid precursor protein intracellular domain (AICD). Mol Biol Cell 18(1): 201-10 (2007).
153. Schoenherr CJ, Anderson DJ. The neuron-restrictive silencer factor (NRSF): a coordinate repressor of multiple neuron-specific genes. Science 267(5202): 1360-3 (1995).
154. Baek SH, Ohgi KA, Rose DW, Koo EH, Glass CK, Rosenfeld MG. Exchange of N-CoR corepressor and Tip60 coactivator complexes links gene expression by NF-kappaB and beta-amyloid precursor protein. Cell 110(1): 55-67. (2002).
155. Alves da Costa C, Sunyach C, Pardossi-Piquard R, Sevalle J, Vincent B, Boyer N, et al. Presenilin-dependent gamma-secretasemediated control of p53-associated cell death in Alzheimer's disease. J Neurosci 26(23): 6377-85 (2006).
156. Ahn KW, Joo Y, Choi Y, Kim M, Lee SH, Cha SH, et al. Swedish amyloid precursor protein mutation increases cell cycle-related proteins in vitro and in vivo. J Neurosci Res 86(11): 2476-87 (2008).
157. Takahashi K, Niidome T, Akaike A, Kihara T, Sugimoto H. Amyloid precursor protein promotes endoplasmic reticulum stressinduced cell death via C/EBP homologous protein-mediated pathway. J Neurochem 109(5): 1324-37 (2009).
158. Zhang YW, Wang R, Liu Q, Zhang H, Liao FF, Xu H. Presenilin/{gamma}-secretase-dependent processing of betaamyloid precursor protein regulates EGF receptor expression. Proc Natl Acad Sci USA 104(25): 10613-8 (2007).
159. Liu Q, Zerbinatti CV, Zhang J, Hoe HS, Wang B, Cole SL, et al. Amyloid Precursor Protein Regulates Brain Apolipoprotein E and Cholesterol Metabolism through Lipoprotein Receptor LRP1. Neuron 56(1): 66-78 (2007).
160. Ryan KA, Pimplikar SW. Activation of GSK-3 and phosphorylation of CRMP2 in transgenic mice expressing APP intracellular domain. J Cell Biol 171(2): 327-35 (2005).
161. Chen AC, Selkoe DJ. Response to: Pardossi-Piquard et al., "Presenilin-Dependent Transcriptional Control of the Abeta-Degrading Enzyme Neprilysin by Intracellular Domains of betaAPP and APLP." Neuron 46, 541-554. Neuron 53(4): 479-83 (2007).
162. Pardossi-Piquard R, Dunys J, Kawarai T, Sunyach C, Alves da Costa C, Vincent B, et al. Response to Correspondence: Pardossi-Piquard et al., "Presenilin-Dependent Transcriptional Control of the Abeta-Degrading Enzyme Neprilysin by Intracellular Domains of betaAPP and APLP." Neuron 46, 541-554. Neuron 53(4): 483-6 (2007).
163. Belyaev ND, Nalivaeva NN, Makova NZ, Turner AJ. Neprilysin gene expression requires binding of the amyloid precursor protein intracellular domain to its promoter: implications for Alzheimer disease. EMBO Rep 10(1): 94-100 (2009).
164. Eisele YS, Baumann M, Klebl B, Nordhammer C, Jucker M, Kilger E. Gleevec Increases Levels of the Amyloid Precursor Protein Intracellular Domain (AICD) and of the A{beta}-degrading Enzyme Neprilysin. Mol Biol Cell (2007).
165. Vazquez MC, Vargas LM, Inestrosa NC, Alvarez AR. c-Abl modulates AICD dependent cellular responses: Transcriptional induction and apoptosis. J Cell Physiol 220(1): 136-43 (2009).
166. Vincent B, Sunyach C, Orzechowski HD, St George-Hyslop P, Checler F. p53-Dependent transcriptional control of cellular prion by presenilins. J Neurosci 29(20): 6752-60 (2009).
167. Dunys J, Sevalle J, Giaime E, Pardossi-Piquard R, Vitek MP, Renbaum P, et al. p53-dependent control of transactivation of the Pen2 promoter by presenilins. J Cell Sci 122(Pt 21): 4003-8 (2009).
168. Hebert SS, Serneels L, Tolia A, Craessaerts K, Derks C, Filippov MA, et al. Regulated intramembrane proteolysis of amyloid precursor protein and regulation of expression of putative target genes. EMBO Rep 7(7): 739-45 (2006).
169. Hampe W, Riedel IB, Lintzel J, Bader CO, Franke I, Schaller HC. Ectodomain shedding, translocation and synthesis of SorLA are stimulated by its ligand head activator. J Cell Sci 113 Pt 24: 4475-85 (2000).
170. Kim DY, Carey BW, Wang H, Ingano LA, Binshtok AM, Wertz MH, et al. BACE1 regulates voltage-gated sodium channels and neuronal activity. Nat Cell Biol 9(7): 755-64 (2007).
171. Lleo A, Berezovska O, Ramdya P, Fukumoto H, Raju S, Shah T, et al. Notch1 competes with the amyloid precursor protein for gamma-secretase and down-regulates presenilin-1 gene expression. J Biol Chem 278(48): 47370-5 (2003).
172. Lleo A, Waldron E, von Arnim CA, Herl L, Tangredi MM, Peltan ID, et al. Low density lipoprotein receptor-related protein (LRP) interacts with presenilin 1 and is a competitive substrate of the amyloid precursor protein (APP) for gamma-secretase. J Biol Chem 280(29): 27303-9 (2005).
173. Kim JW, Kim MJ, Kim KJ, Yun HJ, Chae JS, Hwang SG, et al. Notch interferes with the scaffold function of JNK-interacting protein 1 to inhibit the JNK signaling pathway. Proc Natl Acad Sci USA 102(40): 14308-13 (2005).
174. Roncarati R, Sestan N, Scheinfeld MH, Berechid BE, Lopez PA, Meucci O, et al. The gamma-secretase-generated intracellular domain of beta-amyloid precursor protein binds Numb and inhibits Notch signaling. Proc Natl Acad Sci USA 99(10): 7102-7 (2002).
175. Fischer DF, van Dijk R, Sluijs JA, Nair SM, Racchi M, Levelt CN, et al. Activation of the Notch pathway in Down syndrome: crosstalk of Notch and APP. Faseb J 19(11): 1451-8 (2005).
176. Hoe HS, Magill LA, Guenette S, Fu Z, Vicini S, Rebeck GW. FE65 interaction with the ApoE receptor ApoEr2. J Biol Chem 281(34): 24521-30 (2006).
177. Kinoshita A, Whelan CM, Smith CJ, Mikhailenko I, Rebeck GW, Strickland DK, et al. Demonstration by fluorescence resonance energy transfer of two sites of interaction between the low-density lipoprotein receptor-related protein and the amyloid precursor protein: role of the intracellular adapter protein Fe65. J Neurosci 21(21): 8354-61 (2001).
178. Bao J, Cao C, Zhang X, Jiang F, Nicosia SV, Bai W. Suppression of beta-amyloid precursor protein signaling into the nucleus by estrogens mediated through complex formation between the estrogen receptor and Fe65. Mol Cell Biol 27(4): 1321-33 (2007).
179. Araki Y, Miyagi N, Kato N, Yoshida T, Wada S, Nishimura M, et al. Coordinated metabolism of Alcadein and amyloid beta-protein precursor regulates FE65-dependent gene transactivation. J Biol Chem 279(23): 24343-54 (2004).
180. Yoon IS, Pietrzik CU, Kang DE, Koo EH. Sequences from the low density lipoprotein receptor-related protein (LRP) cytoplasmic domain enhance amyloid beta protein production via the betasecretase pathway without altering amyloid precursor protein/LRP nuclear signaling. J Biol Chem 280(20): 20140-7 (2005).
181. Kim SY, Kim MY, Mo JS, Park HS. Notch1 intracellular domain suppresses APP intracellular domain-Tip60-Fe65 complex mediated signaling through physical interaction. Biochim Biophys Acta 1773(6): 736-46 (2007).
182. Merdes G, Soba P, Loewer A, Bilic MV, Beyreuther K, Paro R. Interference of human and Drosophila APP and APP-like proteins with PNS development in Drosophila. Embo J 23(20): 4082-95 (2004).
183. Osipo C, Golde TE, Osborne BA, Miele LA. Off the beaten pathway: the complex cross talk between Notch and NF-kappaB. Lab Invest 88(1): 11-7 (2008).
184. Brady ME, Ozanne DM, Gaughan L, Waite I, Cook S, Neal DE, et al. Tip60 is a nuclear hormone receptor coactivator. J Biol Chem 274(25): 17599-604 (1999).
185. Frank SR, Parisi T, Taubert S, Fernandez P, Fuchs M, Chan HM, et al. MYC recruits the TIP60 histone acetyltransferase complex to chromatin. EMBO Rep 4(6): 575-80 (2003).
186. Gaughan L, Brady ME, Cook S, Neal DE, Robson CN. Tip60 is a co-activator specific for class I nuclear hormone receptors. J Biol Chem 276(50): 46841-8 (2001).
187. Xiao H, Chung J, Kao HY, Yang YC. Tip60 is a co-repressor for STAT3. J Biol Chem 278(13): 11197-204 (2003).
188. Zhou R, Geiger RC, Dean DA. Intracellular trafficking of nucleic acids. Expert Opin Drug Deliv 1(1): 127-40 (2004).
189. Hass MR, Yankner BA. A {gamma}-secretase-independent mechanism of signal transduction by the amyloid precursor protein. J Biol Chem 280(44): 36895-904 (2005).
190. Chawla S, Vanhoutte P, Arnold FJ, Huang CL, Bading H. Neuronal activity-dependent nucleocytoplasmic shuttling of HDAC4 and HDAC5. J Neurochem 85(1): 151-9 (2003).
191. Linseman DA, Bartley CM, Le SS, Laessig TA, Bouchard RJ, Meintzer MK, et al. Inactivation of the myocyte enhancer factor-2 repressor histone deacetylase-5 by endogenous Ca(2+) //calmodulin-dependent kinase II promotes depolarization-mediated cerebellar granule neuron survival. J Biol Chem 278(42): 41472-81 (2003).
192. McKenzie GJ, Stevenson P, Ward G, Papadia S, Bading H, Chawla S, et al. Nuclear Ca2+ and CaM kinase IV specify hormonal- and Notch-responsiveness. J Neurochem 93(1): 171-85 (2005).
193. Sardi SP, Murtie J, Koirala S, Patten BA, Corfas G. Presenilin-Dependent ErbB4 Nuclear Signaling Regulates the Timing of Astrogenesis in the Developing Brain. Cell 127(1): 185-97 (2006).
194. Huber O, Korn R, McLaughlin J, Ohsugi M, Herrmann BG, Kemler R. Nuclear localization of beta-catenin by interaction with transcription factor LEF-1. Mech Dev 59(1): 3-10 (1996).
195. Sisodia SS. Beta-amyloid precursor protein cleavage by a membrane-bound protease. Proc Natl Acad Sci U S A 89(13): 6075-9 (1992).
196. Rajendran L, Honsho M, Zahn TR, Keller P, Geiger KD, Verkade P, et al. Alzheimer's disease beta-amyloid peptides are released in association with exosomes. Proc Natl Acad Sci U S A 103(30): 11172-7 (2006).
197. Chyung JH, Raper DM, Selkoe DJ. Gamma-secretase exists on the plasma membrane as an intact complex that accepts substrates and effects intramembrane cleavage. J Biol Chem 280(6): 4383-92 (2005).
198. Annaert WG, Levesque L, Craessaerts K, Dierinck I, Snellings G, Westaway D, et al. Presenilin 1 controls gamma-secretase processing of amyloid precursor protein in pre-golgi compartments of hippocampal neurons. J Cell Biol 147(2): 277-94 (1999).
199. Kaether C, Schmitt S, Willem M, Haass C. Amyloid precursor protein and Notch intracellular domains are generated after transport of their precursors to the cell surface. Traffic 7(4): 408-15 (2006).
200. Howe CL, Mobley WC. Signaling endosome hypothesis: A cellular mechanism for long distance communication. J Neurobiol 58(2): 207-16 (2004).
201. Schroer TA. Dynactin. Annu Rev Cell Dev Biol 20: 759-79 (2004).
202. Ehlers MD, Kaplan DR, Price DL, Koliatsos VE. NGF-stimulated retrograde transport of trkA in the mammalian nervous system. J Cell Biol 130(1): 149-56 (1995).
203. Watson FL, Heerssen HM, Moheban DB, Lin MZ, Sauvageot CM, Bhattacharyya A, et al. Rapid nuclear responses to target-derived neurotrophins require retrograde transport of ligand-receptor complex. J Neurosci 19(18): 7889-900 (1999).
204. Bhattacharyya A, Watson FL, Pomeroy SL, Zhang YZ, Stiles CD, Segal RA. High-resolution imaging demonstrates dynein-based vesicular transport of activated Trk receptors. J Neurobiol 51(4): 302-12 (2002).
205. Shrum CK, Defrancisco D, Meffert MK. Stimulated nuclear translocation of NF-kappaB and shuttling differentially depend on dynein and the dynactin complex. Proc Natl Acad Sci U S A 106(8): 2647-52 (2009).
206. Laird FM, Cai H, Savonenko AV, Farah MH, He K, Melnikova T, et al. BACE1, a major determinant of selective vulnerability of the brain to amyloid-beta amyloidogenesis, is essential for cognitive, emotional, and synaptic functions. J Neurosci 25(50): 11693-709 (2005).
207. Sala Frigerio C, Fadeeva JV, Minogue AM, Citron M, Van Leuven F, Staufenbiel M, et al. beta-Secretase cleavage is not required for generation of the intracellular C-terminal domain of the amyloid precursor family of proteins. FEBS J 277(6): 1503-18 (2010).
208. Waldron E, Isbert S, Kern A, Jaeger S, Martin AM, Hebert SS, et al. Increased AICD generation does not result in increased nuclear translocation or activation of target gene transcription. Exp Cell Res (2008).
209. Ho A, Sudhof TC. Binding of F-spondin to amyloid-beta precursor protein: a candidate amyloid-beta precursor protein ligand that modulates amyloid-beta precursor protein cleavage. Proc Natl Acad Sci USA 101(8): 2548-53 (2004).
210. Hoey SE, Williams RJ, Perkinton MS. Synaptic NMDA receptor activation stimulates alpha-secretase amyloid precursor protein processing and inhibits amyloid-beta production. J Neurosci 29(14): 4442-60 (2009).
211. Ma H, Lesne S, Kotilinek L, Steidl-Nichols JV, Sherman M, Younkin L, et al. Involvement of beta-site APP cleaving enzyme 1 (BACE1) in amyloid precursor protein-mediated enhancement of memory and activity-dependent synaptic plasticity. Proc Natl Acad Sci USA 104(19): 8167-72 (2007).
212. Wiley JC, Hudson M, Kanning KC, Schecterson LC, Bothwell M. Familial Alzheimer's disease mutations inhibit gamma-secretasemediated liberation of beta-amyloid precursor protein carboxyterminal fragment. J Neurochem 94(5): 1189-201 (2005).
213. Tesco G, Ginestroni A, Hiltunen M, Kim M, Dolios G, Hyman BT, et al. APP substitutions V715F and L720P alter PS1 conformation and differentially affect Abeta and AICD generation. J Neurochem 95(2): 446-56 (2005).
214. Hecimovic S, Wang J, Dolios G, Martinez M, Wang R, Goate AM. Mutations in APP have independent effects on Abeta and CTFgamma generation. Neurobiol Dis 17(2): 205-18 (2004).
215. Sato T, Dohmae N, Qi Y, Kakuda N, Misonou H, Mitsumori R, et al. Potential link between amyloid beta-protein 42 and C-terminal fragment gamma 49-99 of beta-amyloid precursor protein. J Biol Chem 278(27): 24294-301 (2003).
216. Guardia-Laguarta C, Pera M, Clarimon J, Molinuevo JL, Sanchez-Valle R, Llado A, et al. Clinical, neuropathologic, and biochemical profile of the amyloid precursor protein I716F mutation. J Neuropathol Exp Neurol 69(1): 53-9 (2010).
217. Chen F, Gu Y, Hasegawa H, Ruan X, Arawaka S, Fraser P, et al. Presenilin 1 mutations activate gamma 42-secretase but reciprocally inhibit epsilon-secretase cleavage of amyloid precursor protein (APP) and S3-cleavage of notch. J Biol Chem 277(39): 36521-6 (2002).
218. Moehlmann T, Winkler E, Xia X, Edbauer D, Murrell J, Capell A, et al. Presenilin-1 mutations of leucine 166 equally affect the generation of the Notch and APP intracellular domains independent of their effect on Abeta 42 production. Proc Natl Acad Sci USA 99(12): 8025-30 (2002).
219. Holsinger RM, McLean CA, Beyreuther K, Masters CL, Evin G. Increased expression of the amyloid precursor beta-secretase in Alzheimer's disease. Ann Neurol 51(6): 783-6 (2002).
220. Yang LB, Lindholm K, Yan R, Citron M, Xia W, Yang XL, et al. Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease. Nat Med 9(1): 3-4 (2003).
221. Fukumoto H, Cheung BS, Hyman BT, Irizarry MC. Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease. Arch Neurol 59(9): 1381-9 (2002).
222. Fukumoto H, Rosene DL, Moss MB, Raju S, Hyman BT, Irizarry MC. Beta-secretase activity increases with aging in human, monkey, and mouse brain. Am J Pathol 164(2): 719-25 (2004).
223. Ghosal K, Vogt DL, Liang M, Shen Y, Lamb BT, Pimplikar SW. Alzheimer's disease-like pathological features in transgenic mice expressing the APP intracellular domain. Proc Natl Acad Sci USA 106(43): 18367-72 (2009).
224. Steinbach JP, Muller U, Leist M, Li ZW, Nicotera P, Aguzzi A. Hypersensitivity to seizures in beta-amyloid precursor protein deficient mice. Cell Death Differ 5(10): 858-66 (1998).
225. Vogt DL, Thomas D, Galvan V, Bredesen DE, Lamb BT, Pimplikar SW. Abnormal neuronal networks and seizure susceptibility in mice overexpressing the APP intracellular domain. Neurobiol Aging (2009).
226. Galvan V, Gorostiza OF, Banwait S, Ataie M, Logvinova AV, Sitaraman S, et al. Reversal of Alzheimer's-like pathology and behavior in human APP transgenic mice by mutation of Asp664. Proc Natl Acad Sci USA 103(18): 7130-5 (2006).
227. Leissring MA, Murphy MP, Mead TR, Akbari Y, Sugarman MC, Jannatipour M, et al. A physiologic signaling role for the gamma - secretase-derived intracellular fragment of APP. Proc Natl Acad Sci USA 99(7): 4697-702 (2002).
228. Tu H, Nelson O, Bezprozvanny A, Wang Z, Lee SF, Hao YH, et al. Presenilins form ER Ca2+ leak channels, a function disrupted by familial Alzheimer's disease-linked mutations. Cell 126(5): 981-93 (2006).
229. Zhang H, Sun S, Herreman A, De Strooper B, Bezprozvanny I. Role of presenilins in neuronal calcium homeostasis. J Neurosci 30(25): 8566-80 (2010).
230. Cheung KH, Mei L, Mak DO, Hayashi I, Iwatsubo T, Kang DE, et al. Gain-of-function enhancement of IP3 receptor modal gating by familial Alzheimer's disease-linked presenilin mutants in human cells and mouse neurons. Sci Signal 3(114): ra22 (2010).
231. Cheung KH, Shineman D, Muller M, Cardenas C, Mei L, Yang J, et al. Mechanism of Ca2+ disruption in Alzheimer's disease by presenilin regulation of InsP(3) receptor channel gating. Neuron 58(6): 871-83 (2008).
232. Ward MW, Concannon CG, Whyte J, Walsh CM, Corley B, Prehn JH. The amyloid precursor protein intracellular domain(AICD) disrupts actin dynamics and mitochondrial bioenergetics. J Neurochem 113(1): 275-84 (2010).
233. Vincent I, Jicha G, Rosado M, Dickson DW. Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain. J Neurosci 17(10): 3588-98 (1997).
234. Busser J, Geldmacher DS, Herrup K. Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer's disease brain. J Neurosci 18(8): 2801-7 (1998).
235. Yang Y, Varvel NH, Lamb BT, Herrup K. Ectopic cell cycle events link human Alzheimer's disease and amyloid precursor protein transgenic mouse models. J Neurosci 26(3): 775-84 (2006).
236. Yang Y, Geldmacher DS, Herrup K. DNA replication precedes neuronal cell death in Alzheimer's disease. J Neurosci 21(8): 2661-8 (2001).
237. Jin K, Peel AL, Mao XO, Xie L, Cottrell BA, Henshall DC, et al. Increased hippocampal neurogenesis in Alzheimer's disease. Proc Natl Acad Sci USA 101(1): 343-7 (2004).
238. Ermini FV, Grathwohl S, Radde R, Yamaguchi M, Staufenbiel M, Palmer TD, et al. Neurogenesis and alterations of neural stem cells in mouse models of cerebral amyloidosis. Am J Pathol 172(6): 1520-8 (2008).
239. Naumann N, Alpar A, Ueberham U, Arendt T, Gartner U. Transgenic expression of human wild-type amyloid precursor protein decreases neurogenesis in the adult hippocampus. Hippocampus: (2009).
240. Lopez-Sanchez N, Muller U, Frade JM. Lengthening of G2/mitosis in cortical precursors from mice lacking beta-amyloid precursor protein. Neuroscience 130(1): 51-60 (2005).
241. Bruni P, Minopoli G, Brancaccio T, Napolitano M, Faraonio R, Zambrano N, et al. Fe65, a ligand of the Alzheimer's beta-amyloid precursor protein, blocks cell cycle progression by down-regulating thymidylate synthase expression. J Biol Chem 277(38): 35481-8 (2002).
242. Nakayama K, Ohkawara T, Hiratochi M, Koh CS, Nagase H. The intracellular domain of amyloid precursor protein induces neuronspecific apoptosis. Neurosci Lett 444(2): 127-31 (2008).
243. Kinoshita A, Whelan CM, Berezovska O, Hyman BT. The gamma secretase-generated carboxyl-terminal domain of the amyloid precursor protein induces apoptosis via Tip60 in H4 cells. J Biol Chem 277(32): 28530-6 (2002).
244. Madeira A, Pommet JM, Prochiantz A, Allinquant B. SET protein (TAF1beta, I2PP2A) is involved in neuronal apoptosis induced by an amyloid precursor protein cytoplasmic subdomain. Faseb J 19(13): 1905-7 (2005).
245. Lu DC, Rabizadeh S, Chandra S, Shayya RF, Ellerby LM, Ye X, et al. A second cytotoxic proteolytic peptide derived from amyloid beta-protein precursor. Nat Med 6(4): 397-404 (2000).
246. Park SA, Shaked GM, Bredesen DE, Koo EH. Mechanism of cytotoxicity mediated by the C31 fragment of the amyloid precursor protein. Biochem Biophys Res Commun 388(2): 450-5 (2009).
247. Bertrand E, Brouillet E, Caille I, Bouillot C, Cole GM, Prochiantz A, et al. A short cytoplasmic domain of the amyloid precursor protein induces apoptosis in vitro and in vivo. Mol Cell Neurosci 18(5): 503-11 (2001).
248. Cuesta A, Zambrano A, Royo M, Pascual A. The tumour suppressor p53 regulates the expression of amyloid precursor protein (APP). Biochem J 418(3): 643-50 (2009).
249. Ozaki T, Li Y, Kikuchi H, Tomita T, Iwatsubo T, Nakagawara A. The intracellular domain of the amyloid precursor protein (AICD) enhances the p53-mediated apoptosis. Biochem Biophys Res Commun 351(1): 57-63 (2006).
250. Munoz DG, Wang D, Greenberg BD. Hirano bodies accumulate Cterminal sequences of beta-amyloid precursor protein (beta-APP) epitopes. J Neuropathol Exp Neurol 52(1): 14-21 (1993).
251. Ha S, Furukawa R, Fechheimer M. Association of AICD and Fe65 with Hirano bodies reduces transcriptional activation and initiation of apoptosis. Neurobiol Aging (2010).
252. Belyaev ND, Kellett KA, Beckett C, Makova NZ, Revett TJ, Nalivaeva NN, et al. The transcriptionally active amyloid precursor protein (APP) intracellular domain is preferentially produced from the 695 isoform of APP in a {beta}-secretase dependent pathway. J Biol Chem http://www.jbc.org/cgi/doi/10.1074/jbc.M110.141390: (2010).